Clinical Trial Update: Following of Myeloid-derived Suppressor Cells (MDSC) in Severe Sepsis: What Relationship With Systemic Inflammatory Syndrome?

View source ↗

Summary

The clinical trial investigating myeloid-derived suppressor cells in severe sepsis and their relationship to systemic inflammatory syndrome has been terminated.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Systemic Inflammatory Response Syndrome

Snippet

Sponsor: University Hospital, Limoges | Conditions: Severe Sepsis, Inflammatory Response Syndrome, Systemic | Status: TERMINATED